Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This phase I/II trial studies the side effects and best dose of flavopiridol in treating
patients with previously treated chronic lymphocytic leukemia or lymphocytic lymphoma. Drugs
used in chemotherapy such as flavopiridol work in different ways to stop cancer cells from
dividing so they stop growing or die.